Chromosome 1p loss evaluation in anaplastic oligodendrogliomas

Neuropathology

Volumn 28, Issue 4, 2008, Pages 440-443

  Idbaih, Ahmed ^a,b,c   Kouwenhoven, Mathilde ^d   Jeuken, Judith ^e   Carpentier, Catherine ^a,b   Gorlia, Thierry ^f   Kros, Johan M ^d   French, Pim ^d   Teepen, Johannes L ^g   Delattre, Olivier ^a,h   Delattre, Jean Yves ^a,b,c   Van Den Bent, Martin ^d   Hoang Xuan, Khê ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f EORTC DATA CENTER   (Belgium)

^g CPRLab   (Netherlands)

^h INSTITUT CURIE   (France)

Author keywords

1p; BAC array based comparative genomic hybridization (aCGH); Chromosome; Fluorescent in situ hybridization (FISH); Oligodendroglioma

Indexed keywords

ADULT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHROMOSOME 1P; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR GROWTH;

BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGODENDROGLIOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 44849106242     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2008.00863.x     Document Type: Article

References (20)

1. Cairncross JG, Ueki K, Zlatescu MC et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998 90: 1473 1479.
2. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 145: 1175 1190.
3. Smith JS, Perry A, Borell TJ et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000 18: 636 645.
4. Ino Y, Zlatescu MC, Sasaki H et al. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg 2000 92: 983 990.
5. Kujas M, Lejeune J, Benouaich-Amiel A et al. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol 2005 58: 322 326.
6. Kouwenhoven MC, Kros JM, French PJ et al. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. Eur J Cancer 2006 42: 2499 2503.
7. van den Bent MJ, Carpentier AF, Brandes AA et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 2006 24: 2715 2722.
8. Intergroup Radiation Therapy Oncology Group Trial 9402, Cairncross G, Berkey B, Shaw E et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 2006 24: 2707 2714.
9. Idbaih A, Marie Y, Pierron G et al. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 2005 58: 483 487.
10. Jeuken J, Cornelissen S, Boots-Sprenger S, Gijsen S, Wesseling P. Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors. J Mol Diagn 2006 8: 433 443.
11. Scheie D, Andresen PA, Cvancarova M et al. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors. Am J Surg Pathol 2006 30: 828 837.
12. Belaud-Rotureau MA, Meunier N, Eimer S, Vital A, Loiseau H, Merlio JP. Automatized assessment of 1p36-19q13 status in gliomas by interphase FISH assay on touch imprints of frozen tumors. Acta Neuropathol (Berl) 2006 111: 255 263.
13. Neuvial P, Hupe P, Brito I et al. Spatial normalization of array-CGH data. BMC Bioinformatics 2006 7: 264.
14. Hupe P, Stransky N, Thiery JP, Radvanyi F, Barillot E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 2004 20: 3413 3422.
15. La Rosa P, Viara E, Hupe P et al. VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics 2006 22: 2066 2073.
16. Liva S, Hupe P, Neuvial P et al. CAPweb: a bioinformatics CGH array Analysis Platform. Nucleic Acids Res 2006 34: W477 W481.
17. Jenkins RB, Blair H, Ballman KV et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 2006 66: 9852 9861.
18. Griffin CA, Burger P, Morsberger L et al. Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol 2006 65:988 994.
19. Kubota T, Hirano A, Tanaka R, Takahashi H. Fine structural study of a cerebral tumor characterized by a honeycomb appearance after a 20-year post-mortem interval. Neuropathology 2006 26:158 160.
20. Rickert CH, Korshunov A, Paulus W. Chromosomal imbalances in clear cell ependymomas. Mod Pathol 2006 19:958 962.